We are live on ! Find out more
HUMAW icon

Humacyte Inc Warrant

11 hedge funds and large institutions have $4.55M invested in Humacyte Inc Warrant in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+11
Holders Change %
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
Reduced
Closed
Calls
$312K
Puts
Net Calls
+$312K
Net Calls Change
+$312K

HUMAW Hedge Fund Activity: Q4 2020 in Review

11 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2020, worth a combined $4.55M.

Buyers outnumbered sellers: 11 funds opened new HUMAW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Omni Partners, opening a new position worth an estimated $556K.

  • 11 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $4.55M of Humacyte Inc Warrant stock for Q4 2020.
  • 11 funds opened new Humacyte Inc Warrant positions in Q4 2020 and 0 closed out, a net change of +11 holders.
  • The largest Humacyte Inc Warrant buyer in Q4 2020 was Omni Partners, an estimated $556K added.

Based on aggregated 13F filings for Q4 2020.